1-5 of 5
Sabine Fischer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypoadiponectinemia Is Associated With Progression Toward Type 2 Diabetes and Genetic Variation in the ADIPOQ Gene Promoter

Peter E.H. Schwarz, MD, Gordon W. Towers, PHD, Sabine Fischer, MD, Suresh Govindarajalu, MD, Jan Schulze, MD, Stephan R. Bornstein, MD, Markolf Hanefeld, MD, Francis Vasseur, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1645–1650
https://doi.org/10.2337/dc05-2123
Published: 01 July 2006
View article titled, Hypoadiponectinemia Is Associated With Progression Toward Type 2 Diabetes and Genetic Variation in the <em>ADIPOQ</em> Gene Promoter
Open the PDF for Hypoadiponectinemia Is Associated With Progression Toward Type 2 Diabetes and Genetic Variation in the <em>ADIPOQ</em> Gene Promoter in another window
Journal Articles

In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control

Frank Pistrosch, MD, Jens Passauer, MD, Sabine Fischer, MD, Katja Fuecker, Markolf Hanefeld, MD, Peter Gross, MD
Journal: Diabetes Care
Diabetes Care 2004;27(2):484–490
https://doi.org/10.2337/diacare.27.2.484
Published: 01 February 2004
View article titled, In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control
Open the PDF for In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control in another window
Journal Articles

Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM

Steven M Haffner, MD, Markolf Hanefeld, MD, Sabine Fischer, MD, Katja Fuçker, DIPL CHEM, Wolfgang Leonhardt, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(9):1430–1434
https://doi.org/10.2337/diacare.20.9.1430
Published: 01 September 1997
View article titled, Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM
Open the PDF for Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM in another window
Journal Articles

Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

Markolf Hanefeld, DSc, Sabine Fischer, DSc, Jan Schulze, DSc, Manfred Spengler, PhD, Manfred Wargenau, PhD, Karl Schollberg, PhD, Katja Fücker, DC
Journal: Diabetes Care
Diabetes Care 1991;14(8):732–737
https://doi.org/10.2337/diacare.14.8.732
Published: 01 August 1991
View article titled, Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone
Open the PDF for Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone in another window
Journal Articles

Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM

Markolf Hanefeld, DSc, Sabine Fischer, DSc, Harald Schmechel, DSc, Gisela Rothe, Jan Schulze, DSc, Helmut Dude, MA, Uta Schwanebeck, MA, Ulrich Julius, DSc
Journal: Diabetes Care
Diabetes Care 1991;14(4):308–317
https://doi.org/10.2337/diacare.14.4.308
Published: 01 April 1991
View article titled, Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM
Open the PDF for Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM in another window